Non‐Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol‐Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.

Saved in:
Bibliographic Details
Title: Non‐Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol‐Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.
Authors: Roger, Simon D.1 (AUTHOR) sdroger@bigpond.net.au, Wong, Chew Ming2 (AUTHOR), Vejakama, Phisitt3 (AUTHOR), Rahardjo, Kuspudji Dwitanto4,5 (AUTHOR), Hsu, Bang‐Gee6 (AUTHOR), Lee, Chang Meng7 (AUTHOR), Wu, I‐Wen8 (AUTHOR), Lee, Chin‐Chan8 (AUTHOR), Situmorang, Tunggul Diapari9 (AUTHOR), Krisanapan, Pajaree10 (AUTHOR), Mazlan, Sadanah Aqashiah11 (AUTHOR), Peng, Yu‐Sen12 (AUTHOR), Sarwono, Johanes13 (AUTHOR), De Asis, Norman14 (AUTHOR), Solimen, Domingo15 (AUTHOR), Jonny16 (AUTHOR), Sangthawan, Pornpen17 (AUTHOR), Chen, Jin‐Bor18 (AUTHOR), Wang, Chia‐Liang19 (AUTHOR), Chung, Sungjin20 (AUTHOR)
Source: Nephrology. May2025, Vol. 30 Issue 5, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13205358
DOI:10.1111/nep.70046